• STAT+: Novartis and Lilly turn to nonprofit, instead of FDA, to resolve dispute over drug ad

    2 days ago - By STAT

    In a rare move, the Better Business Bureau National Programs settled a dispute between two big drug companies over a prescription drug ad, suggesting the nonprofit may take a larger role in resolving complaints that might normally be handled by the U.S. Food and Drug Administration.
    The dispute began when Eli Lilly challenged some of the information in an ad that Novartis had run for its Kisqali breast cancer treatment. Specifically, Lilly objected to language about the overall survival rate in Kisqali clinical trials that suggested the drug was superior to similar cancer medications...
    Read more ...